The FDA has authorized booster doses of the Pfizer-BioNTech COVID-19 vaccine for kids 5-11.
booster doses of the Pfizer-BioNTech COVID-19 vaccine for kids 5-11, clearing the way for younger Americans to bolster their protection against the coronavirus.The FDA has authorized booster doses of the Pfizer-BioNTech COVID-19 vaccine for kids 5-11
"While it has largely been the case that COVID-19 tends to be less severe in children than adults, the omicron wave has seen more kids getting sick with the disease and being hospitalized, and children may also experience longer term effects, even following initially mild disease,” FDA Commissioner Robert Califf said in a statement.
Assuming no changes are made to the FDA's recommendation from the CDC, booster shots could be given as early as Friday. While the coronavirus is comparitively more dangerous to adults, kids can get severely ill – more than 350 children ages 5 to 11 have died, according to data from the CDC.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA authorizes Pfizer COVID-19 booster shots for children ages 5 to 11The FDA has granted emergency use authorization for a booster dose of Pfizer/BioNTech's COVID-19 vaccine for children ages 5 to 11 at least five months after completion of the primary vaccine series.
Weiterlesen »
FDA authorizes Pfizer COVID-19 booster shots for children ages 5 to 11The FDA has granted emergency use authorization for a booster dose of Pfizer/BioNTech's COVID-19 vaccine for children ages 5 to 11 at least five months after completion of the primary vaccine series.
Weiterlesen »
FDA approves Pfizer COVID booster shots for kids 5 to 11The FDA has granted emergency use authorization for a booster dose of Pfizer/BioNTech's COVID-19 vaccine for children ages 5 to 11.
Weiterlesen »
FDA authorizes Pfizer Covid-19 booster shots for children ages 5 to 11The US Food and Drug Administration has granted emergency use authorization for a booster dose of Pfizer/BioNTech's Covid-19 vaccine for children ages 5 to 11 at least five months after completion of the primary vaccine series.
Weiterlesen »
FDA authorizes Pfizer COVID-19 booster shots for children ages 5 to 11 -The US Food and Drug Administration has granted emergency use authorization for a booster dose of Pfizer/BioNTech’s Covid-19 vaccine for children ages 5 to 11 at least five months after completion of the primary vaccine series. Pfizer requested this EUA at the end of April, citing company data that showed that a third vaccine dose raised Omicron-fighting antibodies by 36...
Weiterlesen »
FDA authorizes Pfizer Covid booster for children 5 to 11 years oldA study in February found that two doses of the vaccine offered little protection against the omicron variant.
Weiterlesen »